Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6541 studies found for:    delta-24
Show Display Options
Rank Status Study
1 Completed Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Tenckhoff Catheter placement;   Drug: Ad5-delta24RGD
2 Unknown  Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
3 Completed DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Conditions: Brain Cancer;   Central Nervous System Diseases
Interventions: Drug: DNX-2401;   Procedure: Tumor Removal
4 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide
5 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: interferon gamma
6 Unknown  Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis
Condition: Stenosis
Intervention: Drug: atorvastatin
7 Completed
Has Results
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants
Condition: Schizophrenia
Intervention: Drug: Paliperidone
8 Completed
Has Results
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: any human insulin or analog insulin(s) given in any regimen by subcutaneous injection
9 Terminated
Has Results
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
Conditions: Leukemia;   Lymphoma;   Malnutrition;   Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific;   Weight Changes
Interventions: Dietary Supplement: Ensure;   Dietary Supplement: PediaSure;   Drug: cyproheptadine hydrochloride
10 Terminated
Has Results
Dynepo Infrequent Dosing Study
Conditions: Anemia;   Kidney Failure
Interventions: Drug: Dynepo (Epoetin delta);   Drug: Dynepo
11 Completed
Has Results
Effect of Orlistat in Body Composition
Conditions: Obesity;   Overweight
Interventions: Drug: Orlistat;   Drug: Placebo
12 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
13 Recruiting RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate
Condition: Multiple Sclerosis
Intervention: Drug: Rebif®
14 Terminated
Has Results
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
Condition: Back Pain
Interventions: Drug: Parathyroid hormone (PTH) (1-84);   Drug: Alendronate
15 Not yet recruiting ASIS for Botox in Cervical Dystonia
Conditions: Cervical Dystonia Adults ,;   Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
16 Unknown  Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients
Condition: Gastroesophageal Reflux Disease
Intervention: Procedure: Endoscopy
17 Completed
Has Results
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: placebo
18 Completed
Has Results
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Biological: octagam 10%
19 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
20 Completed
Has Results
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: teriparatide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years